Taylor Asset Management’s Pfizer PFE Stock Holding History

Taylor Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-14,229	Closed	-$491K	–	34
2017 Q4	$491K	Sell	14,229 -6,851	-33%	-$234K	0.17%	26
2017 Q3	$714K	Buy	+21,080	New	+$678K	0.23%	20
2016 Q1	–	Sell	-441,310	Closed	-$13.5M	–	39
2015 Q4	$13.5M	Buy	441,310 +77,575	+21%	+$2.44M	3.25%	14
2015 Q3	$10.8M	Buy	363,735 +4,426	+1%	+$142K	2.29%	17
2015 Q2	$11.4M	Buy	359,309 +9,803	+3%	+$319K	2.08%	17
2015 Q1	$11.5M	Sell	349,506 -30,250	-8%	-$962K	1.84%	21
2014 Q4	$11.2M	Buy	+379,756	New	+$10.9M	1.47%	25
2014 Q2	–	Sell	-383,761	Closed	-$11.7M	–	34
2014 Q1	$11.7M	Buy	+383,761	New	+$11.4M	1.33%	24

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Taylor Asset Management's PFE Position: Q1 2018 in Review

Taylor Asset Management sold out of Pfizer (PFE) in Q1 2018, closing a stake of 14,229 shares — an estimated $491K sold.

Taylor Asset Management first reported a position in PFE in Q1 2014 and held it in 8 quarters. The position peaked at $13.5M in Q4 2015. 2,230 funds tracked by Wall St. Rank hold PFE as of Q1 2018.

Taylor Asset Management reported no remaining Pfizer position as of Q1 2018 after selling out during the quarter.
Taylor Asset Management sold 14,229 Pfizer shares in Q1 2018, an estimated $491K.
Taylor Asset Management first reported a position in Pfizer in Q1 2014 and held it in 8 quarters.
Taylor Asset Management's Pfizer position peaked at $13.5M in Q4 2015.
2,230 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.

Based on Taylor Asset Management's 13F filing for Q1 2018, filed 14 May 2018.